Daily Roundup
Tuesday, 7th April 2026
Last updated: 21:00 | Max Version 🚀
TLX.ASX GYG.ASX ARC.ASX ENN.ASX CGF.ASX
Market Roundup: Strong Earnings, Strategic Partnerships, and Pipeline Advancements
Telix Pharmaceuticals delivered an impressive start to the year, reporting 11% quarter-over-quarter revenue growth in Q1 2026 and reaffirming its FY 2026 revenue guidance of $950 million to $970 million. The company's Precision Medicine division was a standout, with revenue up 16% quarter-over-quarter. Telix also highlighted advancements in its therapeutics pipeline, including positive results from the Phase 3 ProstACT trial and progress in other key programs.
Guzman y Gomez (GYG) also had a strong quarter, with network sales in Australia growing 19.5%. This was driven by continued guest demand, operational excellence, and strategic initiatives like the successful launch of a new Uber Eats partnership and the expansion of a pilot for GYG's proprietary order management system. The company remains on track to open 32 new restaurants in Australia this fiscal year, including 23 drive-thrus.
In other news, ARC Funds Limited has agreed to acquire a 25% passive equity stake in Ausbiz Group, a digital media business focused on financial markets content and investor engagement. This transaction is consistent with ARC's strategy of making selective investments in the financial services and related sectors.
Elanor Investors Group also had a busy quarter, announcing a $125 million balance sheet recapitalization with Rockworth Capital Partners. This will facilitate the repayment of existing debt and provide additional working capital. Elanor is also progressing initiatives to enhance its corporate governance, including the establishment of a separate independent trustee and responsible entity board for its managed funds.
Finally, Bank of Queensland (BOQ) has entered into a strategic capital partnership with Challenger Limited. This includes a $3.7 billion whole-of-loan sale and a forward flow arrangement for equipment finance assets. The transaction is expected to optimize BOQ's funding base, support growth, and enhance shareholder returns.
Overall, it's been an eventful start to the year for these companies, with a mix of strong financial results, strategic partnerships, and pipeline advancements that should position them well for the future.
References
| TLX.ASX | 08:28 | 72 Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement |
| GYG.ASX | 08:31 | 69 Q3 FY26 Quarterly Sales Update |
| ARC.ASX | 09:16 | 68 ARC Conditional Deal to Acquire Minority Stake in Ausbiz |
| ENN.ASX | 09:22 | 67 Market Update |
| CGF.ASX | 08:41 | 66 BOQ Announces Capital Partnership with Challenger |